FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology and concerns cDNA coding human dysferlin, a genetically engineered construct wherein such cDNA is cloned, a recombinant adenovirus and a pharmaceutical composition. The described genetically engineered construct comprises an expression plasmid adenovirus vector pAd/CMV/V5-DEST, wherein the codon-optimised cDNA having a sequence presented in SEQ ID NO: 1 and coding human dysferlin is cloned according to recombination sites attB1 and attB2. The recombinant replication defect adenovirus serotype 5 is prepared with using such genetically engineered construct and included into the pharmaceutical composition in an effective amount.
EFFECT: inventions enables recovering the disturbed dysferlin expression and/or function in the skeletal striated muscle tissue and resulting in the positive effect.
4 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF MYODYSTROPHY CORRECTION USING ADENO-ASSOCIATED VIRAL VECTOR IN EXPERIMENT | 2022 |
|
RU2821544C1 |
| METHOD FOR CORRECTING MUSCULAR DYSTROPHY USING PLASMID DNA IN DYSFERLIN-DEFICIENT MICE | 2022 |
|
RU2805357C1 |
| NUCLEIC ACID SYNTHETIC MOLECULE (VERSIONS), MAMMAL CELL EXPRESSION VECTOR, MAMMAL HOST CELL AND METHOD OF EXPRESSING ANTIGEN PROTEIN OF HUMAN EPIDERMAL GROWTH FACTOR-2 (HER2/neu) OR SHORTENED FORM THEREOF | 2004 |
|
RU2397249C2 |
| FUSED PROTEINS OF CARCINOEMBRYONAL ANTIGEN | 2005 |
|
RU2380375C2 |
| CODON-OPTIMISED SEQUENCES AND PHARMACEUTICAL COMPOSITION FOR RECOVERY OF BLOOD VESSELS | 2014 |
|
RU2557385C1 |
| FUSED PROTEIN OF TELOMERASE REVERSE TRANSCRIPTASE, NUCLEOTIDES CODING THEM, AND USING THEM | 2007 |
|
RU2473691C2 |
| RECOMBINANT PLASMID pAd-SM, CODING HUMAN PROTEINS SOX2 AND C-MYC, BEING BASE FOR PRODUCTION OF VIRULENT ADENOVIRUSES DESIGNED FOR PRODUCTION OF INDUCED PLURIPOTENT HUMAN CELLS | 2012 |
|
RU2495127C2 |
| GENE DELIVERY VECTOR CAPABLE TO INDUCE CELL APOPTOSIS | 1998 |
|
RU2252255C2 |
| RECOMBINANT PLASMID DNA PAD5-F CARRYING OF ADENOVIRUS TYPE 5 GENOME FRAGMENT WITH DELETION IN GENE E1B-55K AND STRAIN OF MUTANT ADENOVIRUS ADE 12 EXHIBITING SELECTIVE ANTITUMOR ACTIVITY | 2001 |
|
RU2194755C2 |
| IMMUNOBIOLOGICAL AGENT AND A METHOD FOR USE THEREOF FOR INDUCING SPECIFIC IMMUNITY TO THE MIDDLE EASTERN RESPIRATORY SYNDROME VIRUS (VERSIONS) | 2018 |
|
RU2709659C1 |
